Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)
The article focuses on the baseline characteristics, including blood and urine metal levels, in participants of the Trial to Assess Chelation Therapy 2 (TACT2). The study investigates the impact of heavy metal exposure on cardiovascular health and explores the potential of chelation therapy to reduce cardiovascular risks. The research highlights
June 26, 2025
No Comments